CAS 1422527-84-1

Tafasitamab

CAS : 1422527-84-1

Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell

Degré de pureté : SDS-PAGE:95.2%;SEC-HPLC:99.3%

Couleur et forme : Liquid

Masse moléculaire : 147.41 kDa

Ref: TM-T77135

Tafasitamab

CAS : 1422527-84-1

Tafasitamab

Degré de pureté : ≥95%

Ref: 54-BUP20105

Tafasitamab

CAS : 1422527-84-1

Anti-Human CD19 Monoclonal Antibody

Ref: 3D-CLA1373